High growth potential Ion Labs, Inc. operates in the dietary supplements space with a stated revenue range of $50M-$100M and a 51-200 employee base, indicating scale and a need for scalable manufacturing partnerships, regulatory-compliant CDMO capabilities, and capacity planning to support new client formulas.

Full service capabilities The company offers end-to-end contract development and manufacturing for capsules, powders, gummies, tablets, and liquids, suggesting opportunities for sales reps to position as a one-stop solution for clients seeking formulation, packaging, and regulatory alignment under one vendor.

Regulatory excellence Operating from a cGMP and FDA-registered facility with a focus on meeting label claims and regulatory standards presents a compelling selling point to brands aiming to accelerate time-to-market and reduce compliance risk.

Strategic partnerships As part of the Ourvita Group with a clear emphasis on turnkey growth, there is potential to cross-sell services to Ourvita portfolio brands and explore co-development or private-label opportunities that leverage established capabilities and brand alignment.

Technological edge Adoption of modern tech stack including SAP, Power BI, Microsoft 365, and PWA indicates efficient operations, data-driven decision making, and scalable client portals, which can be leveraged in conversations to highlight reliability, transparency, and performance dashboards for clients.